*  Neurocutaneous melanosis: clinical features of large congenital melanocytic nevi in patients with manifest central nervous...
These patients are considered to have neurocutaneous melanosis, a disorder ... Patients with a large congenital melanocytic nevus (LCMN) may have associated leptomeningeal melanocytosis with or without ... RESULTS: Of the 289 patients with LCMN, 33 had manifest CNS melanosis. In all 33 in whom symptomatic neurocutaneous melanosis ... These patients are considered to have neurocutaneous melanosis, a disorder that, when symptomatic or otherwise manifest ...
  http://www.biomedsearch.com/nih/Neurocutaneous-melanosis-clinical-features-large/8859278.html
*  Neurocutaneous melanosis - Wikipedia
... undiagnosed patients with neurocutaneous melanosis. Once a patient with neurocutaneous melanosis becomes symptomatic, little ... Regardless of the presence of malignancy, patients with symptomatic neurocutaneous melanosis generally have a poor prognosis ... The presence of a Dandy-Walker malformation along with neurocutaneous melanosis, as occurs in 10% of symptomatic patients, ... As most patients with neurocutaneous melanosis are asymptomatic, those who are diagnosed through MR imaging are not guarantied ...
  https://en.wikipedia.org/wiki/Neurocutaneous_melanosis
*  Final Diagnosis -- Case 696
Arunkumar MJ, Ranjan A, Jacob M, Rajshekhar V (2001) Neurocutaneous melanosis: a case of primary intracranial melanoma with ... Symptomatic NCM occurs in 7.5% of the patients suffering from large congenital melanocytic nevi (2). Finally, blue nevus is a ... Diffuse melanosis is associated with congenital intradermal benign pigmented nevi in a rare nonfamilial disease called ... neurocutaneous melanosis (NCM). This condition encompasses benign as well as malignant melanocytic tumors of the central ...
  http://path.upmc.edu/cases/case696/dx.html
*  Congenital melanocytic nevus
While not all patients are symptomatic, there can be diverse neurologic findings that typically present by 2 years of age. CMN ... Neurocutaneous melanosis is when a CMN is associated with neuromelanosis, a congenital error in ectodermal morphogenesis ... neurocutaneous melanosis, premature aging syndrome, occult spinal dysraphism, and possibly neurofibromatosis type 1, and other ... Print Patient Handout Images (46) Contributors: William M. Lin MD, Susan Burgin MD, Belinda Tan MD, PhD, Lowell A. Goldsmith MD ...
  https://www.visualdx.com/visualdx/diagnosis/congenital-melanocytic-nevus?moduleId=103&diagnosisId=52631
*  Pediatric Skin Lesions with Predisposition to Cancer Mark A. Bechtel, M.D.
neck Patients with more than 20 satellite nevi have a 5 1 fold increased risk of neurocutaneous 5.1 melanosis. 34% of patients ... pressure Seizures Hydrocephalus Cranial nerve palsy Hemiparesis Developmental delays y Symptomatic Neurocutaneous Melanosis ... Neurocutaneous melanosis (cont.) CMN typically involve the lumbosacral region, posterior thorax, and especially the head and ... MRI Findings in Neurocutaneous Melanosis Diagnosis established by MRI Characteristic hyper intense regions in T1 - weighted ...
  http://textlab.io/doc/23212276/pediatric-skin-lesions-with-predisposition-to-cancer-mark..
*  Medical Challenges for People With a Nevus | Nevus Outreach
Neurocutaneous Melanocytosis (NCM). (This used to be called neurocutaneous melanosis, but we're talking about the same thing). ... A person with symptomatic NCM should be under the care of a neurologist. ... If the seizures can be controlled, the patient can lead a relatvely normal life. ...
  https://www.nevus.org/medical-challenges
*  Congenital melanocytic nevus
... healthcare professionals gain a thorough knowledge base of psychiatric disorder information to offer the best patient care. Get ... NRAS Q61 mutations were noted in 12 of 15 patients with multiple CMN and neurocutaneous melanosis.) Krengel, S, Scope, A, Dusza ... The prognosis of symptomatic NCM is poor. Neurologic symptoms often progress rapidly and lead to death within several months to ... In addition, in those patients with neurocutaneous melanosis, the excision of the CMN in no way modifies the risk for primary ...
  http://www.psychiatryadvisor.com/dermatology/congenital-melanocytic-nevus/article/593911/
*  Neurocutaneous melanosis
Are you sure your patient has neurocutaneous melanosis? What are the typical findings for this disease?. Neurocutaneous ... Those who become symptomatic during infancy do poorly, with the worst prognosis associated with Dandy-Walker malformation, ... If you are able to confirm that the patient has neurocutaneous melanosis, what treatment should be initiated?. For cosmetic ... If you are able to confirm that the patient has neurocutaneous melanosis, what treatment should be initiated? ...
  https://www.thecardiologyadvisor.com/pediatrics/neurocutaneous-melanosis/article/623495/
*  Dr.K. Lakshminarayanan, Pediatric Neurologist in Chennai - Fortis Malar Hospital | sehat
Symptomatic Neurocutaneous Melanosis in a Child. JAMA Neurol. 2013 Feb 18. [Epub ahead of print] ... We served over 10,000 patients from United States. Post your medical treatment enquiry. We will connect and guide you to the ... Help other patients, and let the doctor know how he's doing. Dr.K. Lakshminarayanan's Hospital/Clinic & Staff. Ease of ... He is a qualified and highly skilled pediatric neurologist with a special interest in managing patients with Epilepsy/fits/ ...
  https://www.sehat.com/dr-k-lakshminarayanan-pediatric-neurologist-chennai
*  Intracranial melanocytic meningeal tumours and melanosis oculi: case report and literature review | BMC Cancer | Full Text
Three years later, due to a symptomatic growth, the patient underwent surgical debulking of the lesion with resolution of the ... Brat D: Meningeal Melanocytoma, Neurocutaneous Melanosis, and Primary Meningeal Melanom. Russell and Rubinstein's pathology of ... Melanosis oculi. Black and white picture of the left eye: the part of the sclera involved by the bluish discoloration has been ... The patient underwent 3D-Conformal Radiation Therapy (3D-CRT) of the lesion of the cavernous sinus (total dose 5040 cGy with a ...
  https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-12-220
*  Cancernet - Universidad de Chile
43] They include diffuse melanocytosis (diffuse melanosis) and neurocutaneous melanosis, melanocytoma, and malignant melanoma. ... Patients with multiple brain metastases are treated with WBRT. Surgery is reserved only for large symptomatic lesions or for ... Treatment for patients with a single metastasis:. About 10% to 20% of patients with cancer will have a single brain metastasis ... 51] Breast cancer patients with brain metastases typically have more favorable prognoses than patients with brain metastases ...
  http://bitmed.med.uchile.cl/Summary.html/CDR62900.html
*  Rare Cancer News & Clinical Trials ยป PubMed - Neuroendocrine Tumor
Neurocutaneous Melanosis Presenting as Cavernous Hemangioma Persistent Abdominal Pain.. J Craniofac Surg. 2017 Mar;28(2):e168- ... Majority were symptomatic with only 98 patients (24.0%) asymptomatic. The most common presentation of non-functional tumors was ... RESULTS: Twenty-two patients have small cell carcinoma, and 5 patients have large cell neuroendocrine carcinoma. Patients who ... RESULTS: A total of 16 patients met inclusion criteria. Six patients were diagnosed with stage I; these patients had 83.3% 2- ...
  http://news.rare-cancer.org/PubMed_-_Neuroendocrine_Tumor/
*  USE OF A PEPTIDE AS A THERAPEUTIC AGENT - Patent application
Neurocutaneous melanosis, Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency, Neurodegeneration with brain ... 0120]The term "a patient in need of treatment with a neuroprotective drug" as used herein will refer to any patient who ... for either its symptomatic treatment or for prevention of progressive decline in nerve function. [0142]The thickening and ... 0125]The determination of which patients may benefit from treatment with a neuroprotective drug in patients who have no ...
  http://www.patentsencyclopedia.com/app/20100204140
*  TRAP-14 AS A THERAPEUTIC AGENT - Patent application
Neurocutaneous melanosis, Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency, Neurodegeneration with brain ... 0121]The term "a patient in need of treatment with a neuroprotective drug" as used herein will refer to any patient who ... for either its symptomatic treatment or for prevention of progressive decline in nerve function. [0143]The thickening and ... 0126]The determination of which patients may benefit from treatment with a neuroprotective drug in patients who have no ...
  http://www.patentsencyclopedia.com/app/20100210559